Media Resources

2021
4 October

New study estimates over nine million people living with type 1 diabetes
1 October

Analogue Insulin on WHO Model List of Essential Medicines
7 June

MEPs can deliver strong message to Commission on TRIPS waiver
26 May

WHO Members States must not miss opportunity to improve lives of over 460 million people with diabetes
26 April

Nearly 400 MEPs and MPs Join Chorus of Voices Calling for a TRIPS Waiver on COVID-19 Vaccines
31 March

HAI Statement on the Oslo Medicines Initiative
2020
25 November

Health Action International Statement on the European Commission Pharmaceutical Strategy
12 November

HAI Statement to the 73rd WHA on public health, innovation and IP
4 October

HAI Statement to the WHO Executive Board – COVID-19
25 September

HAI Statement on Improving Access to Insulin
15 September

HAI Statement to the 70th Session of the WHO Regional Committee for Europe
19 June

COVID-19: Future of Pharmaceuticals Webinar
17 May

Medical Technologies for COVID-19 Developed with Public Money Must be Recognised as Global Public Goods
8 May

HAI during COVID-19
17 April

Statement on the Results of EP Plenary on COVID-19 Response
27 March

Guarantee transparency, affordability and availability of EU funded therapies for COVID-19, demand MEPs
22 January

CJEU ruling is victory that resonates for all in favour of greater transparency
2019
6 November

Expert Panel Discusses Concern on Use of Publicly Funded Knowledge in Medicines Development
17 October

EU Lawmakers Raise Alarm at Lack of Commitment to Enforcing Clinical Trial Data Transparency
17 October

Les législateurs de l’UE sonnent l’alarme sur le manque d’engagement à faire respecter la transparence des données des essais cliniques
19 September

Half of Cancer Drug Approvals Rely on Results of Potentially Biased Clinical Trials
10 July

Health Action International Comments on WHO Decision on Long-acting Analogue Insulin
7 June

Breaking Down Barriers to Accessing Internationally Controlled Essential Medicines Key to Ending Pain and Suffering of Millions
27 May

Snakebite Incidents, Response, & Antivenom Supply (Uganda)
27 May

Snakebite Incidents, Response, & Antivenom Supply (Kilifi County, Kenya)
27 May

HAI Snakebite Project in Sub-Saharan Africa
27 May

Policy Brief- WHA 72- The need for Global Action to Reduce Snakebite Death and Disability
27 May

Statement to WHA72 on Access to Medicines and Vaccines
24 May

Statement to WHA72 on the Global Challenge of Antimicrobial Resistance
17 April

HAI Welcomes European Parliament Backing of SPC Manufacturing Waiver